IGF1R expression
|
Thymoma
|
IGF1R expression
|
Thymoma
|
everolimus Resistant: C3 – Early Trials
|
everolimus Resistant: C3 – Early Trials
|
IGF1R expression
|
Thymic Carcinoma
|
IGF1R expression
|
Thymic Carcinoma
|
everolimus Resistant: C3 – Early Trials
|
everolimus Resistant: C3 – Early Trials
|
IGF1R expression
|
Ewing Sarcoma
|
IGF1R expression
|
Ewing Sarcoma
|
IGF-1R inhibitor Sensitive: D – Preclinical
|
IGF-1R inhibitor Sensitive: D – Preclinical
|
IGF1R expression
|
Osteosarcoma
|
IGF1R expression
|
Osteosarcoma
|
IGF-1R inhibitor Sensitive: D – Preclinical
|
IGF-1R inhibitor Sensitive: D – Preclinical
|
IGF1R expression
|
Soft Tissue Sarcoma
|
IGF1R expression
|
Soft Tissue Sarcoma
|
IGF-1R inhibitor Sensitive: D – Preclinical
|
IGF-1R inhibitor Sensitive: D – Preclinical
|